Lepara Zahid, Lepara Orhan, Fajkić Almir, Rebić Damir, Alić Jasmin, & Spahović Hajrudin. (2020). Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer. Sciendo.
Chicago Style (17th ed.) CitationLepara Zahid, Lepara Orhan, Fajkić Almir, Rebić Damir, Alić Jasmin, and Spahović Hajrudin. Serum Malondialdehyde (MDA) Level as a Potential Biomarker of Cancer Progression for Patients with Bladder Cancer. Sciendo, 2020.
MLA (9th ed.) CitationLepara Zahid, et al. Serum Malondialdehyde (MDA) Level as a Potential Biomarker of Cancer Progression for Patients with Bladder Cancer. Sciendo, 2020.
Warning: These citations may not always be 100% accurate.